Itraconazole

Edina Avdic, Pharm.D.
Pediatric Dosing Author: Lisa Hutchins, Pharm.D.

INDICATIONS

Following fungal infections in immunocompromised and non-immunocompromised patients:
- Aspergillosis: treatment-intolerant of or refractory to amphotericin B therapy
- Pulmonary and extrapulmonary blastomycosis
- Histoplasmosis, including chronic cavitary pulmonary disease and disseminated non-meningeal histoplasmosis
Onychomycosis in non-immunocompromised patients (oral capsule):
- Onychomycosis of the toenail, with or without fingernail involvement, due to dermatophytes (tinea unguium)
- Onychomycosis of the fingernail due to dermatophytes (tinea unguium).
Oropharyngeal and esophageal candidiasis (oral liquid)
Neutropenic fever in patients with suspected fungal infection (oral liquid).

There's more to see -- the rest of this topic is available only to subscribers.

All content is protected by copyright and may not be used for AI model training or other unauthorized purposes.